---
title: "D.E. Shaw discloses net short position in Valneva shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296115291.md"
description: "D.E. Shaw has disclosed a net short position of 0.45% in Valneva shares, according to data from the AMF."
datetime: "2026-08-17T13:37:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296115291.md)
  - [en](https://longbridge.com/en/news/296115291.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296115291.md)
generator: "portal-rs"
---

# D.E. Shaw discloses net short position in Valneva shares

-   D.E. Shaw disclosed a 0.45% net short position in Valneva shares, AMF data showed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valneva SE published the original content used to generate this news brief on August 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [VALN.US](https://longbridge.com/en/quote/VALN.US.md)

## Related News & Research

- [Citadel Advisors discloses net short position in Valneva shares](https://longbridge.com/en/news/295249575.md)
- [Citadel Advisors discloses net short position in Valneva shares](https://longbridge.com/en/news/295114180.md)
- [EMA validates Pfizer and Valneva’s Lyme disease vaccine](https://longbridge.com/en/news/296088348.md)
- [Valneva GAAP EPS of -€0.35, revenue of €65.84M; reaffirms FY 2026](https://longbridge.com/en/news/295751501.md)
- [European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application](https://longbridge.com/en/news/295959393.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**